Recent news on Imigran

New pain relief option for migraine sufferers  -  25 May 2007
TV3 News,The government drug funding body has decided to fund generic sumatriptan tablets – new forms of GlaxoSmithKline's migraine relief drug Imigran.

UK Plans to Make Naproxen Pain Drug Available OTC  -  Apr 12, 2007
Reuters.uk,L: Quote, Profile , Research) migraine pill Imigran, or sumatriptan, as well as antibiotic eye drops. Industry analysts predict more European and North

UK Plans To Make Naproxen Pain Drug Available OTC  -  Apr 12, 2007
Javno.hr,Other products made available OTC recently include GlaxoSmithKline Plc's migraine pill Imigran, or sumatriptan, as well as antibiotic eye drops.

Glaxo's Trexima More Effective Against Migraines (Update1)  -  Apr 3, 2007
BloombergImitrex and a low-dose, over-the-counter formula known as Imigran brought in 711 million pounds ($1.4 billion) last year for Glaxo,

Pozen: On Track With New Pain Medications  -  Mar 12, 2007
Seeking Alpha,The Imigran/Imitrex franchise posted global sales of £711 million ($1315 million) at Glaxo in 2006, £551 million ($1019 million) of which was in the US

GSK to export to 70 markets from Poznan  -  Mar 1, 2007
Polish Market,Overall, the transfer concerns three preparations: one used in epilepsy treatment (Lamictal) and two for migraine pain (Imigran and Naramig).

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional